GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma

Clinical trial NCT00293423 · COMPLETED

Trial details

NCT number: NCT00293423
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2005-11-18
Primary completion: 2013-01-12
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.